The analysis finds that under the terms of a US-UK trade deal agreed in December, the NHS will divert billions of pounds from essential services to pay for the new drugs, which could lead to more than 200,000 deaths.
Ministers have defended the deal as a way to help British drug exports avoid US tariffs and provide patients access to vital medicines, but critics have accused the Labor Party of caving in to pressure from Donald Trump.
Lucy Huff talks to columnist Aditya Chakraborty – watch on youtube
